Monteris wins U.S. and Canadian nods for its NeuroBlate tumor "cooker"
Monteris Mecical scores regulatory wins in the U.S. and in Canada, also touting positive clinical trial results for the NeuroBlate MRI-guided brain tumor treatment system.
Monteris Medical  won a regulatory nod in the U.S. and in Canada for its NeuroBlate MRI-guided tumor ablation device, the company said.
Monteris calls NeuroBlate a tumor "cooker" which uses an MRI-guided laser system to heat and kill brain tumors. Positive results in the 1st-in-human trials were published  earlier this month in the Journal of Neurosurgery.